我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

急性冠脉综合征患者血Th1/Th2漂移与冠脉病变特点及中医虚实证候的相关性(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2012年第2期
页码:
209-212,226
栏目:
临床研究
出版日期:
2012-04-25

文章信息/Info

Title:
Correlation between Th1/Th2 drift in blood and characteristics of coronary lesions, deficiency syndrome and sufficiency syndrome in patients with acute coronary syndrome
作者:
姜红菊13周苏宁2王 蕾1史新华3
(1.山东中医药大学第一临床学院,山东 济南 250355;2.山东省立医院心血管内科, 山东 济南 250021;3.山东中医药大学第二附属医院心血管内科,山东 济南 250001)
Author(s):
JIANG Hong-ju ZHOU Su-ning WANG Lei SHI Xin-hua
(Department of Cardiology, Second Affiliated Hospital, Shandong University of Traditional Chinese Medicine, Jinan 250001, Shandong, China)
关键词:
急性冠脉综合征Th1/Th2漂移冠脉病变特点虚实
Keywords:
ACS Th1/Th2 drift coronary lesion characteristics deficiency syndrome sufficiency syndrome
分类号:
R541.4
DOI:
-
文献标识码:
A
摘要:
目的:探讨急性冠脉综合征(acute coronary syndrome,ACS)患者血Th1/Th2漂移与冠脉病变特点及胸痹虚实证候的相关性。方法:选取2010年5月~9月在山东省立医院及山东中医药大学第二附属医院心脏内科病房就诊行经皮冠状动脉造影(coronary arteriography,CAG)的患者66例,包括不稳定型心绞痛(unstable angina,UAP)患者22例、急性心肌梗死(acute myocardial infarction,AMI)患者11例、稳定型冠心病(SAP)患者33例,健康对照组20例。所有纳入对象均应用ELISA监测血干扰素γ(interferon-γ,IFN-γ)、白介素2 (interleukin-2,IL-2)、白介素4 (interleukin-4,IL-4)、白介素10(interleukin-10,IL-10)水平。冠状动脉造影采用Gensini积分、冠脉病变支数分析冠脉病变特点,并进行胸痹的辩证分型。结果: ①UAP组、AMI组患者IFN-γ、IL-2水平较SAP、正常对照组有显著升高(P<0.05),且存在AMI组>UAP组>SAP组,然而,各组间IL-4、IL-10水平均无明显差异。②ACS组Gensini积分与SAP组比较有显著差异。UAP组、AMI组、SAP组患者IFN-γ、IL-2水平与Gensini积分均呈显著正相关;IL-4、IL-10水平与Gensini积分均呈负相关。③1支病变组与2支病变组之间IFN-γ、IL-2水平均无显著差异,但均较3支病变组细胞因子水平低(P<0.05)。2支病变组与3支病变组之间IL-4、IL-10水平均无显著差异,但均较1支病变组细胞因子水平低(P<0.05)。④中医虚证组IL-2、IFN-γ水平及Genisi积分均较实证组明显增高(P<0.05)。结论:①血Th1/Th2向Th1方向的漂移与ACS发生有关,与冠脉病变的程度是相关的。②虚证患者冠脉病变程度较实证患者严重。③IFN-γ、IL-2水平增高,可作为中医胸痹虚证微观辨证指标。
Abstract:
AIM:To study the correlation between Th1/Th2 drift in blood and characteristics of coronary lesions and to provide a clinical basis for introducing Th1/Th2 drift to the microdifferentiation of deficiency syndrome and sufficiency syndrome of xiongbi in traditional Chinese medicine (TCM). METHODS: All study patients underwent percutaneous coronary intervention (PCI) including 22 cases with unstable angina (UA), 11 cases with acute myocardial infarction (AMI), six cases with syndrome X, and six cases with old myocardial infarction (OMI). During PCI, the characteristics of coronary lesions were evaluated by Gensini integral and the number of coronary arteries with plaque, and TCM syndrome differentiations were made. The healthy control group consisted of 20 cases. Serum levels of IFN-γ, IL-2, IL-4, and IL-10 were detected by ELISA. RESULTS: Levels of IFN-γ, IL-2 in UA group, AMI group and OMI group were all significantly higher than those in the control group (P<0.05), with IFN-γ in AMI group >UA group>OMI group. No significant difference was seen in levels of IL-2 among AMI, UA and OMI groups, but IL-2 in AMI group was higher than in the UA group. No significant difference in the levels of IL-4 and IL-10 was observed between groups. Levels of IFN-γ and IL-2 in ACS were positively related to the level of Gensini integral, but levels of IL-4 and IL-10 were negatively related to the level of Gensini integral. No significant difference was seen in the levels of IFN-γ and IL-2 between the group of one coronary artery with plaque and the group of two coronary arteries with plaque but were lower than those in the group of three coronary arteries with plaque (P<0.05). Levels of IL-4 and IL-10 were similar in the group of two coronary arteries with plaque and the group of three coronary arteries with plaque (P>0.05), but the level in the group of one coronary artery with plaque was higher than in the groups of two and three coronary arteries with plaque (P<0.05). Levels of IFN-γ, IL-2 and Gensini integral in sufficiency syndrome were significantly higher than those in deficiency syndrome (P<0.05). CONCLUSION: Increased levels of IFN-γ and IL-2 are not only predispositions of ACS, but are also aggravating factors of coronary artery plaques. Increased levels of IFN-γ and IL-2 can be used as indicators of sufficiency syndrome.

参考文献/References

[1]Harvey EJ,Ramji DP.Interferon-gamma and atherosclerosis: pro-oranti-atherogenic[J].Cardiovasc Res, 2005,67(1):11-20.

[2]Upadhya S,Mooteri S,Peckham N,et al.Atherogenic effect of interleukin-2 and antiatherogenic effect of interleukin-2 antibody in apo-E-deficient mice[J].Angiology,2004, 55(3):289-294.

[3]Caligiuri G,Rudling M,Ollivier V,et al.Interleukin-10 deficiency increases atherosclerosis,thrombosis,and low-density lipoproteins in apolipoprotein-E knock out mice[J].Mol Med,2003,9(1):10-17.

[4]Potteaux S,Esposito B,Van Oostrom O,et al.Leukocyte-derived interleukin-10 is required for protection against atherosclerosis in low-density lipoprotein receptor knock-out mice[J].Arterioscler Thromb Vasc Biol,2004,24(8):1474-1478.

[5]Von Der Thusen JH,Kuiper J,Fekkes ML,et al.Attenuation of atherogenesis by systemic and local adenovirus-mediated gene transfer of interleukin-10 in LDLR-/-mice[J].FASEB J,2001,15(14):2730-2732.

[6]Pinderski LJ,Fischbein MP,Subbanagounder G,et al.Over expression of interleukin-10 by activated T-lymphocytes inhibits atherosclerosis in LDL-receptor-deficient Mice by altering lymphocyte and macrophage phenotypes[J].Circ Res,2002,90(10):1064-1071.

[7]Caligiuri G,Rudling M,Ollivier V,et al.Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein-E knock out mice[J].Mol Med,2003,9(1-2):10-17.

[8]程 翔,廖玉华,李 彬,等.急性冠脉综合征患者辅助性T细胞亚群变化及意义[J].中国免疫学杂志,2005, 21(1):67-69.

[9]程 翔,廖玉华,李 彬,等.不稳定型心绞痛患者外周血辅助性T淋巴细胞功能失衡的意义[J].临床心血管病杂志,2005,21(9):532-534.

[10]Szodoray P,Timar O,Veres K,et al.TH1/TH2 imbalance, meas-ured by circulating and intracytoplasmic inflammatory cytokines--immunological alterations in acute coronary syndrome and stable coronary artery disease[J].Scand J Immunol,2006,64(3):336-344.

[11]任 毅,陈可冀,张敏州,等.405例冠心病患者冠状动脉造影结果与中医证型的相关性[J].中医杂志,2010,51(8):725-728.

备注/Memo

备注/Memo:
收稿日期:2011-08-28.基金项目:山东省中医药科技发展计划资金资助(2009-124) 作者简介:姜红菊,主任医师,博士生 Email: jianghongju@medmail.com.cn
更新日期/Last Update: 2012-04-01